DFF332
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DFF332, covering 2026-03-03 to 2026-03-03. Get the full timeline:
Most recent: Clinical Trial Update: DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies [Phase 1]